Answers are grounded in this paper and cite their sources.
Background/Objectives: High-intensity gait training (HIT) improves walking outcomes in adult neurologic rehabilitation, but its application to pediatric inpatient rehabilitation remains underexplored. This narrative review examines the evidence relevant to pediatric HIT and discusses intervention definition, clinical implementation, patient selection, potential benefits, safety, and research priorities. Literature Search and Selection: A targeted narrative review of peer-reviewed literature in PubMed, CINAHL, and MEDLINE (searched March–July 2026; final search 30 July 2026), supplemented by reference-list hand-searching, was conducted on HIT, high-intensity interval training (HIIT), and related locomotor interventions in pediatric and adult neurologic rehabilitation. The published evidence was supplemented by practice-based experience from pediatric inpatient rehabilitation, which is identified separately from published findings. Results: HIT emphasizes repetitive, task-specific stepping performed at an intentionally increased cardiovascular and/or neuromuscular demand and can be organized using the frequency, intensity, time, and type framework. Adult neurologic HIT protocols commonly target approximately 70–85% of age-predicted maximum heart rate, but an optimal pediatric intensity has not been established. Direct pediatric HIT evidence remains very limited, and related work consists largely of small, pilot, frequency-based, or mechanistic studies. Related evidence from pediatric locomotor training and HIIT, together with adult neurologic HIT studies, provides indirect support for feasibility and potential improvements in gait speed, endurance, functional mobility, and physical fitness. However, definitions of intensity, dosing parameters, outcome measures, and adverse event reporting vary considerably, and small, heterogeneous studies preclude firm conclusions. Conclusions: HIT is a promising, individualized framework for pediatric neurologic rehabilitation, but current evidence is insufficient to support a universal prescription or designation as standard care. Prospective controlled studies, standardized reporting of prescribed and achieved intensity, systematic safety monitoring, and longer-term evaluations of functional and participation outcomes are needed.
No takes yet. Share an insight, caveat, or question.
Herzog et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: